Pembrolizumab Immunotherapy Improved Endometrial Cancer Survival. Harris E. JAMA 2023 Apr 5. doi: 10.1001/jama.2023.5623.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Harris E. Pembrolizumab Immunotherapy Improved Endometrial Cancer Survival. JAMA 2023 Apr 5. doi: 10.1001/jama.2023.5623.
PMID: 37018002